BMS Sees Growth Products’ Contributions To Total Revenue Increase In Q3

Camzyos, Breyanzi Sales Rose By Triple Digits

 
• By Mandy Jackson
  
Bristol's legacy products, including Eliquis and Revlimid, continue to add the most to total revenue (Shutterstock)

More from Earnings

More from Scrip